TSLP and asthma: Produced TSLP antibody blocks the upstream immune cascade and restores steroid resistance, while budesonide suppresses the transcription of downstream inflammatory genes, jointly alleviating asthma symptoms in severe asthma mice and steroid‐resistant asthmatic mice, compared to inhaled budesonide product or injected tezepelumab.